The global cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) treatment market size was valued at USD 3.02 billion in 2024 and is expected to reach USD 4.30 billion by 2032, at a CAGR of 4.50% during the forecast period
Read MoreThe global acute coronary syndrome market size was valued at USD 13.77 billion in 2025 and is expected to reach USD 20.65 billion by 2033, at a CAGR of 5.20% during the forecast period
Read MoreThe global neonatal jaundice management market size was valued at USD 425.85 million in 2024 and is expected to reach USD 715.43 million by 2032, at a CAGR of 6.70% during the forecast period
Read MoreFind out how Smart Vital Sign Monitor of VitalLeads changes the world of healthcare by providing real-time monitoring, precision, and remote monitoring in Australia.
Read More